Open AccessIn Reply
Author(s) -
Grande Enrique,
MolinaCerrillo Javier,
AlonsoGordoa Teresa
Publication year - 2020
Publication title -
the oncologist
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2020-0336
Subject(s) - medicine , palbociclib , oncology , cancer , metastatic breast cancer , breast cancer
This letter to the editor responds to commentary on the recently reported PALBONET trial results, which focused on the role of Palbociclib in patients with low‐grade pancreatic neuroendocrine tumors.